House advances broad PFAS and chemical restrictions in consumer products; debate focuses on lead limits and implementation

The House took up a second reading of S.25, a broad package of restrictions on PFAS and other chemicals across multiple consumer-product categories, and moved to propose to the Senate to amend the bill after extended floor discussion.

The Member from Bennington presented the measure and described it as a continuation of prior work on PFAS (Act 36 of 2021). She said the bill extends prohibitions to cosmetics and menstrual products, cookware, textiles, juvenile products and artificial turf; it includes definitions derived from FDA and other states, phased-in effective dates (many provisions to take effect Jan. 1, 2026, with later phases in 2027–2028), and a combination of a community engagement plan and an implementation plan for agencies to return recommendations. The presenter emphasized public-health concerns, saying PFAS and certain other chemicals are linked to adverse effects on the liver, endocrine and immune systems and to increased cancer risks.

The measure specifies that prohibitions apply to intentionally added chemicals and, in the case of artificial turf, to PFAS introduced during manufacturing or processing. The bill would add an enforcement pathway through the attorney general’s certificate-of-compliance process; manufacturers would have 60 days to respond to a certificate request, and the AG may postpone a compliance date for up to one year where feasibility is shown.

Floor exchanges focused on technical and economic consequences. The Member from Lowell and the Member from Coventry (who read a letter from a local cosmetic manufacturer) raised concerns about a proposed 5 parts-per-million lead limit in cosmetics scheduled for the July 1, 2027 phase-in. They urged consideration of a 10 parts-per-million standard cited in FDA guidance and industry letters, arguing the stricter 5 ppm figure could put small Vermont manufacturers at a disadvantage. The presenter noted the CDC and EPA health guidance and said states such as Washington and Oregon have different thresholds; she also cited committee research showing most tested products fall at or below federal guidance but that a 5 ppm standard would affect a measurable minority of products.

Other members questioned definitions (e.g., apparel vs. textiles), the scope of exemptions (military and personal protective equipment), the evidence for consumer exposure pathways, and the potential cost impacts for manufacturers and consumers. The presenter replied that agencies and experts provided testimony and that the implementation and engagement plans are meant to address these practical concerns.

After questions and remarks, the House voted by voice to propose to the Senate to amend the bill as recommended by the House Human Services Committee and ordered third reading.